19-47021156-C-G
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2
The NM_002517.4(NPAS1):āc.109C>Gā(p.Pro37Ala) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000932 in 1,588,188 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_002517.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -8 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
NPAS1 | NM_002517.4 | c.109C>G | p.Pro37Ala | missense_variant | 2/12 | ENST00000602212.6 | NP_002508.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
NPAS1 | ENST00000602212.6 | c.109C>G | p.Pro37Ala | missense_variant | 2/12 | 1 | NM_002517.4 | ENSP00000469142.1 | ||
NPAS1 | ENST00000449844.6 | c.109C>G | p.Pro37Ala | missense_variant | 1/11 | 1 | ENSP00000405290.1 | |||
NPAS1 | ENST00000602189.5 | c.-171+1159C>G | intron_variant | 5 | ENSP00000472679.1 |
Frequencies
GnomAD3 genomes AF: 0.000145 AC: 22AN: 151578Hom.: 0 Cov.: 31
GnomAD3 exomes AF: 0.000186 AC: 38AN: 204366Hom.: 0 AF XY: 0.000106 AC XY: 12AN XY: 112848
GnomAD4 exome AF: 0.0000877 AC: 126AN: 1436610Hom.: 0 Cov.: 32 AF XY: 0.0000757 AC XY: 54AN XY: 713406
GnomAD4 genome AF: 0.000145 AC: 22AN: 151578Hom.: 0 Cov.: 31 AF XY: 0.000149 AC XY: 11AN XY: 74016
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | May 04, 2022 | The c.109C>G (p.P37A) alteration is located in exon 1 (coding exon 1) of the NPAS1 gene. This alteration results from a C to G substitution at nucleotide position 109, causing the proline (P) at amino acid position 37 to be replaced by an alanine (A). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at